Volume | 68,066 |
|
|||||
News | - | ||||||
Day High | 1.22 | Low High |
|||||
Day Low | 0.99 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Universe Pharmaceuticals Inc | UPC | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.99 | 0.99 | 1.22 | 1.15 | 1.01 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
254 | 68,066 | US$ 1.16 | US$ 78,937 | - | 0.75 - 12.48 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
15:00:00 | 100 | US$ 1.15 | USD |
Universe Pharmaceuticals Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.17M | 3.63M | - | 40.14M | -8.74M | -2.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Universe Pharmaceuticals News
Date | Time | Source | News Article |
---|---|---|---|
8/31/2023 | 15:10 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
8/16/2023 | 15:10 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
8/04/2023 | 07:30 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
8/04/2023 | 07:30 | GlobeNewswire Inc. | Universe Pharmaceuticals INC Announces Receipt of Nasdaq.. |
7/27/2023 | 15:05 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
7/27/2023 | 09:15 | GlobeNewswire Inc. | Universe Pharmaceuticals INC Announces Share Consolidation |
7/05/2023 | 15:30 | Edgar (US Regulatory) | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
3/07/2023 | 07:00 | GlobeNewswire Inc. | Universe Pharmaceuticals INC Receives Nasdaq Notification.. |
12/21/2022 | 07:00 | GlobeNewswire Inc. | Universe Pharmaceuticals INC Announces Inclusion of Six.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical UPC Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.91 | 1.23 | 0.80 | 1.02 | 28,134 | 0.24 | 26.37% |
1 Month | 1.08 | 1.43 | 0.80 | 1.10 | 22,307 | 0.07 | 6.48% |
3 Months | 1.42 | 2.07 | 0.75 | 1.15 | 46,898 | -0.27 | -19.01% |
6 Months | 3.8178 | 5.88 | 0.75 | 2.57 | 101,445 | -2.67 | -69.88% |
1 Year | 10.02 | 12.48 | 0.75 | 4.83 | 116,529 | -8.87 | -88.52% |
3 Years | 31.56 | 71.94 | 0.75 | 23.44 | 353,897 | -30.41 | -96.36% |
5 Years | 31.56 | 71.94 | 0.75 | 23.44 | 353,897 | -30.41 | -96.36% |
Universe Pharmaceuticals Description
Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications. |